Senate Minority Whip John Thune (R-S.D.) said bipartisan legislation to overhaul the 340B program could be introduced as soon as [...] …
Year: 2024
Drug manufacturer Bausch Health announced it will exempt all Arkansas providers and pharmacies from its 340B contract pharmacy policy, including [...] …
As part of a report on incentivizing use of accountable care organizations (ACOs), Congress’ primary research arm recently recommended excluding [...] …
A small business lobbying organization, created as a more conservative alternative to the U.S. Chamber of Commerce, this week launched [...] …
Japanese drugmaker Takeda recently announced refunds to 340B covered entities for 28 drugs, including one of its top-selling attention-deficit medications. [...] …
SPONSORED CONTENT
TIP: When negotiating Single Case Agreements (SCA), it’s important to include payment terms. An SCA without terms can lead to lengthy delays in
The 340B drug discount program—and congressional activity associated with it—remained a hot topic for lobbyists in the first three months [...] …
Following the recent death of former Arkansas governor and U.S. Sen. David Pryor, he is being remembered for his important [...] …
Attorneys for both covered entities and drug manufacturers say they expect a significant number of filings to the newly re-established [...] …
A drug industry vendor and a conservative non-profit each urged a full federal appeals court to rehear a case on [...] …